Becton, Dickinson and Co. | BDX
Stock Price
224.00
Daily Change
-1.27 -0.56%
Monthly
-6.79%
Yearly
-6.23%
Q4 Forecast
234.13


Peers Price Chg Day Year Date
Terumo 3,073.00 35.00 1.15% -35.75% Nov/22
Agilent 133.89 1.78 1.35% 5.74% Nov/22
Abbott 117.76 0.42 0.36% 14.47% Nov/22
Align Technology 225.74 -2.44 -1.07% 2.85% Nov/22
Avanos Medical 18.60 0.58 3.22% -12.35% Nov/22
Baxter International 33.22 0.23 0.68% -7.77% Nov/22
Becton, Dickinson and Co. 224.00 -1.27 -0.56% -6.23% Nov/22
Bio-Rad Laboratories 332.99 7.77 2.39% 7.01% Nov/22
Boston Scientific 90.00 -1.54 -1.68% 61.78% Nov/22
Cooper Companies 100.86 0.97 0.97% 18.89% Nov/22
Danaher 235.96 1.01 0.43% 6.57% Nov/22
Dexcom 72.82 -1.66 -2.23% -35.53% Nov/22
Edwards Lifesciences 70.52 0.14 0.20% 5.15% Nov/22
Exact Sciences 52.91 -0.16 -0.30% -19.82% Nov/22
Globus Medical 84.72 -0.19 -0.22% 82.90% Nov/22
Hologic 78.97 0.25 0.32% 10.08% Nov/22
Integra LifeSciences 23.58 0.58 2.52% -40.38% Nov/22
Intuitive Surgical 547.61 -3.08 -0.56% 72.20% Nov/22
J&J 155.20 -0.32 -0.21% 1.77% Nov/22
Masimo 172.96 3.84 2.27% 83.86% Nov/22
Medtronic 86.39 1.62 1.92% 9.40% Nov/22
Patterson Companies 20.46 0.18 0.89% -37.14% Nov/22
Insulet 262.93 0.93 0.36% 39.89% Nov/22
Stryker 385.03 -4.62 -1.19% 31.12% Nov/22
Teleflex 191.72 1.14 0.60% -12.83% Nov/22
Thermo Fisher Scientific 513.07 -2.88 -0.56% 4.54% Nov/22
Tandem Diabetes Care 30.81 0.07 0.23% 61.73% Nov/22
Dentsply International 18.78 0.15 0.78% -40.05% Nov/22
Zimmer Biomet Holdings 109.55 1.24 1.14% -3.42% Nov/22

Indexes Price Day Year Date
US500 5969 20.64 0.35% 30.93% Nov/22

Becton, Dickinson and Co. traded at $224.00 this Friday November 22nd, decreasing $1.27 or 0.56 percent since the previous trading session. Looking back, over the last four weeks, Becton, Dickinson and Co. lost 6.79 percent. Over the last 12 months, its price fell by 6.23 percent. Looking ahead, we forecast Becton, Dickinson and Co. to be priced at 234.13 by the end of this quarter and at 225.60 in one year, according to Trading Economics global macro models projections and analysts expectations.

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through segments such as BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.